Peptide science, explained

Peptides, decoded.

Tirzepatide activates two gut-hormone receptors. Retatrutide activates three. Here's what each one is, how it works, and what the research shows.

2 → 3

receptors targeted: tirzepatide vs retatrutide

39

amino acids in tirzepatide's chain

1×

weekly injection, thanks to a fatty-acid side chain

Important to know

Not a magic fix.

Tirzepatide, retatrutide and other peptides are not magic weight-loss elixirs. They are prescription medicines that support weight loss alongside a healthier lifestyle, never instead of it, and only with a doctor's guidance.

Approved as an add-on

Tirzepatide for weight management is approved for use together with a reduced-calorie diet and increased physical activity.5

Trials included lifestyle change

Everyone in the main weight-loss trials, including the placebo groups, also followed a diet and exercise programme.1

Stopping brings weight back

When people stopped tirzepatide, they regained much of the lost weight. Lasting results depend on lasting habits.16

Never buy or use peptides without a prescription and a doctor's supervision. Prepare for that conversation

US FDA approved

Tirzepatide

Two receptors. One weekly peptide.

A dual GIP and GLP-1 receptor agonist, approved in the US as Mounjaro for type 2 diabetes and as Zepbound for weight management and obstructive sleep apnea.

GIPGLP-1
Investigational · Phase 3 complete

Retatrutide

Three receptors. One weekly peptide.

An investigational triple agonist of the GIP, GLP-1 and glucagon receptors. Phase 3 trials reported in 2026, but it is not approved anywhere yet.

GIPGLP-1Glucagon

Peptides 101

What is a peptide?

A short chain of amino acids — the same building blocks as proteins, just fewer of them. Many hormones are peptides. Tirzepatide and retatrutide are lab-made peptides modelled on GIP, a hormone the gut releases after you eat.

Each bead is one amino acid. Tirzepatide has 39.

Mechanism

Incretins, explained.

Incretins are gut hormones that prompt the pancreas to release insulin after a meal, mainly when blood sugar is high. Each peptide switches on a different set of hormone receptors.

ReceptorTirz.Reta.
  • GLP-1Insulin, fullness, slower digestion●●
  • GIPInsulin, fat-tissue energy handling●●
  • GlucagonEnergy use, liver fat burning–●

Tirzepatide · SURMOUNT-1

Up to

20.9%

average weight loss over 72 weeks on the 15 mg dose, versus 3.1% on placebo, in 2,539 adults without diabetes.1

Average weight loss at 72 weeks (%)
  • Placebo3.1
  • 5 mg15.0
  • 10 mg19.5
  • 15 mg20.9

Retatrutide · Phase 2

Up to

24.2%

average weight loss over 48 weeks on the 12 mg dose, versus 2.1% on placebo, in 338 adults without diabetes.6

Average weight loss at 48 weeks (%)
  • Placebo2.1
  • 1 mg8.7
  • 4 mg17.1
  • 8 mg22.8
  • 12 mg24.2

Design

Built to last a week.

Natural GIP and GLP-1 last only minutes in the blood. Both peptides carry a fatty-acid side chain that binds albumin, a blood protein, which slows their clearance to a half-life of about 5–6 days.59

Tirzepatide~5-day half-life

Retatrutide~6-day half-life

One segment = one day of the week.

Side effects

Know what to expect.

In trials of both peptides, the most common side effects were digestive. They were mostly mild to moderate and most frequent while the dose was being increased.

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Decreased appetite
  • Indigestion

Peptide library

Beyond the headline peptides.

BPC-157, GHK-Cu, cagrilintide, tesamorelin and more, each rated by how strong the evidence really is.

Compare

Which is which?

Tirzepatide

US FDA approvedLearn more

Retatrutide

InvestigationalLearn more

Receptor targets

GIPGLP-1
GIPGLP-1Glucagon

Type

Dual agonist
Triple agonist

Status

Approved (US 2022 onward)
Phase 3 complete; US filing planned Q1 2027

Brand names

Mounjaro, Zepbound
None yet

Development code

LY3298176
LY3437943

Schedule

Once weekly injection
Once weekly injection (in trials)

Half-life

About 5 days5
About 6 days9

Headline weight result

Up to 20.9% at 72 weeks
SURMOUNT-1, phase 31
Up to 25.0% at 80 weeks
TRIUMPH-1, phase 3, company-reported11

Headline HbA1c result

−2.30 points at 40 weeks
SURPASS-2, type 2 diabetes2
−2.02 points at 24 weeks
Phase 2, type 2 diabetes7

Most common side effects

Nausea, diarrhea, vomiting, constipation
Nausea, diarrhea, vomiting, constipation; dose-related heart-rate rise; unusual skin sensations

Developer

Eli Lilly and Company
Eli Lilly and Company

These results come from separate trials with different people, doses and durations. They are not a head-to-head comparison.

Safety

Safety comes first.

Both peptides act on powerful hormone systems. Here is what the label and the trials say to watch for.

Common to both

Nausea, diarrhea, vomiting, constipation and reduced appetite — usually mild to moderate, and most likely while the dose is being increased.

Tirzepatide label5

  • Thyroid C-cell tumors
  • Pancreatitis
  • Gallbladder problems
  • Low blood sugar
  • Kidney problems
  • Birth control pills
  • Anaesthesia and sedation

Retatrutide in trials6

Dose-related heart-rate increases were seen in phase 2. Long-term safety is still being studied in phase 3.

Important

Beware of “research peptides.”

Both peptides are sold online as “research chemicals” or “not for human use.” These are not approved medicines: their identity, purity, dose and sterility are unknown. Regulators, including the US FDA, have warned about unapproved and counterfeit versions.15 In 2026 the Philippine FDA issued public health warnings against unregistered “research use” tirzepatide and retatrutide products.13 Retatrutide is not approved anywhere, so any product sold outside a clinical trial is unregulated.

Only use medicines prescribed by a licensed clinician and dispensed by a licensed pharmacy.

Community

Want to know more?

Join the Gtides community on Telegram. Scan the code with your phone camera, or tap the button if you're already on your phone.

Discussion and research updates only. Nothing is sold, and no medical advice is given.

Scan to join on Telegram

Community

Want to know more?

Scan the code with your phone camera to join the Gtides community on Telegram.

Open in Telegram

On your phone? Tap the button instead.

Discussion and research updates only. Nothing is sold, and no medical advice is given. By joining you agree to our community rules.